Hepatocyte nuclear factor 1β suppresses canonical Wnt signaling through transcriptional repression of lymphoid enhancer-binding factor 1

被引:5
|
作者
Chan, Siu Chiu [1 ]
Hajarnis, Sachin S. [2 ,3 ]
Vrba, Sophia M. [1 ,4 ]
Patel, Vishal [2 ]
Igarashi, Peter [1 ,2 ]
机构
[1] Univ Minnesota, Sch Med, Dept Med, Minneapolis, MN 55455 USA
[2] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA
[3] Otsuka Pharmaceut Dev & Commercializat Inc, Princeton, NJ USA
[4] NIAID, Lab Clin Immunol & Microbiol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA
基金
美国国家卫生研究院;
关键词
HNF-1β β -catenin; LEF1; kidney; histone methylation; tissue-specific transcription factor; Wnt pathway; beta-catenin (B-catenin); transcription repressor; T-cell factor (TCF); cystic kidney disease; WNT/BETA-CATENIN; KIDNEY DEVELOPMENT; GENE-EXPRESSION; RENAL CYSTS; FACTOR-I; HNF-1-BETA; ACTIVATION; DISEASE; MECHANISMS; COMPONENTS;
D O I
10.1074/jbc.RA120.015592
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hepatocyte nuclear factor-1 beta (HNF-1 beta) is a tissue-specific transcription factor that is required for normal kidney development and renal epithelial differentiation. Mutations of HNF-1 beta produce congenital kidney abnormalities and inherited renal tubulopathies. Here, we show that ablation of HNF-1 beta in mIMCD3 renal epithelial cells results in activation of beta-catenin and increased expression of lymphoid enhancer-binding factor 1 (LEF1), a downstream effector in the canonical Wnt signaling pathway. Increased expression and nuclear localization of LEF1 are also observed in cystic kidneys from Hnf1b mutant mice. Expression of dominant-negative mutant HNF-1 beta in mIMCD3 cells produces hyperresponsiveness to exogenous Wnt ligands, which is inhibited by siRNA-mediated knockdown of Lef1. WT HNF-1 beta binds to two evolutionarily conserved sites located 94 and 30 kb from the mouse Lef1 promoter. Ablation of HNF-1 beta decreases H3K27 trimethylation repressive marks and increases beta-catenin occupancy at a site 4 kb upstream to Lef1. Mechanistically, WT HNF-1 beta recruits the polycomb-repressive complex 2 that catalyzes H3K27 trimethylation. Deletion of the beta-catenin-binding domain of LEF1 in HNF-1 beta-deficient cells abolishes the increase in Lef1 transcription and decreases the expression of downstream Wnt target genes. The canonical Wnt target gene, Axin2, is also a direct transcriptional target of HNF-1 beta through binding to negative regulatory elements in the gene promoter. These findings demonstrate that HNF-1 beta regulates canonical Wnt target genes through long-range effects on histone methylation at Wnt enhancers and reveal a new mode of active transcriptional repression by HNF-1 beta.
引用
收藏
页码:17560 / 17572
页数:13
相关论文
共 50 条
  • [31] miR-300 regulates tumor proliferation and metastasis by targeting lymphoid enhancer-binding factor 1 in hepatocellular carcinoma
    Chen, Yufo
    Guo, Yuanyuan
    Li, Yawei
    Yang, Jingwen
    Liu, Jing
    Wu, Qiong
    Wang, Rui
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2019, 54 (04) : 1282 - 1294
  • [32] miR-449a Regulates the Chondrogenesis of Human Mesenchymal Stem Cells Through Direct Targeting of Lymphoid Enhancer-Binding Factor-1
    Paik, Seungil
    Jung, Ho Sun
    Lee, Seulgi
    Yoon, Dong Suk
    Park, Min Sung
    Lee, Jin Woo
    STEM CELLS AND DEVELOPMENT, 2012, 21 (18) : 3298 - 3308
  • [33] Detection of Lymphoid Enhancer-Binding Factor 1 (LEF1) by Flow Cytometry Is Not Entirely Specific for Chronic Lymphocytic Leukemia (CLL)
    Ondrejka, S. L.
    Bodo, J.
    Gay, B.
    Katanik, D. A.
    Finbar, E.
    Namiotka, F.
    Henrich, L.
    Polz, C.
    Hsi, E. D.
    LABORATORY INVESTIGATION, 2014, 94 : 368A - 368A
  • [34] REPRESSION OF INVOLUCRIN GENE-EXPRESSION BY TRANSCRIPTIONAL ENHANCER FACTOR 1 (TEF-1)
    TAKAHASHI, H
    KOBAYASHI, H
    MATSUO, S
    IIZUKA, H
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 1995, 287 (08) : 740 - 746
  • [35] Detection of Lymphoid Enhancer-Binding Factor 1 (LEF1) by Flow Cytometry Is Not Entirely Specific for Chronic Lymphocytic Leukemia (CLL)
    Ondrejka, S. L.
    Bodo, J.
    Gay, B.
    Katanik, D. A.
    Finbar, E.
    Namiotka, F.
    Henrich, L.
    Polz, C.
    Hsi, E. D.
    MODERN PATHOLOGY, 2014, 27 : 368A - 368A
  • [36] Repression of the inhibin α-subunit gene by the transcription factor CCAAT/enhancer-binding protein-β
    Burkart, AD
    Mukherjee, A
    Sterneck, E
    Johnson, PF
    Mayo, KE
    ENDOCRINOLOGY, 2005, 146 (04) : 1909 - 1921
  • [37] Lymphoid Enhancer-binding Factor 1 Expression Precedes Dentin Sialophosphoprotein Expression during Rat Odontoblast Differentiation and Regeneration
    Nakatomi, Mitsushiro
    Ida-Yonemochi, Hiroko
    Ohshima, Hayato
    JOURNAL OF ENDODONTICS, 2013, 39 (05) : 612 - 618
  • [38] Flow Cytometric Analysis of Lymphoid Enhancer-Binding Factor 1 in Diagnosis of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
    Amador-Ortiz, Catalina
    Goolsby, Charles L.
    Peterson, LoAnn C.
    Wolniak, Kristy L.
    McLaughlin, Janet L.
    Gao, Juehua
    Chen, Yi-Hua
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2015, 143 (02) : 214 - 222
  • [39] Rac1 augments Wnt signaling by stimulating β-catenin-lymphoid enhancer factor-1 complex assembly independent of β-catenin nuclear import
    Jamieson, Cara
    Lui, Christina
    Brocardo, Mariana G.
    Martino-Echarri, Estefania
    Henderson, Beric R.
    JOURNAL OF CELL SCIENCE, 2015, 128 (21) : 3933 - 3946
  • [40] Expression and Proliferation-Promoting Role of Lymphoid Enhancer-Binding Factor 1 in Human Clear Cell Renal Carcinoma
    Shang, Donghao
    Bi, Rumei
    Han, Tiandong
    Wang, Daye
    Tian, Ye
    Liu, Yuting
    CANCER INVESTIGATION, 2014, 32 (07) : 368 - 374